Blockchain In Genomics Market Report 2026

Blockchain In Genomics Market Overview

• Blockchain In Genomics market size has reached to $1.01 billion in 2025 • Expected to grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 18.3% • Growth Driver: Impact Of Rising Digital Tool Adoption On Blockchain In Genomics Market • Market Trend: Partnerships Advance DNA-Based Blockchain Identity Verification • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Blockchain In Genomics Market?

Blockchain in genomics refers to the application of blockchain technology in the field of genomics, combining the decentralized and secure nature of blockchain with the storage, sharing, and analysis of genomic data. It provides a blockchain-based platform for individuals to securely store and share the genomic data. The main services of blockchain in genomics market covered are utility tokens and blockchain platforms. Utility tokens in the context of cryptocurrency and blockchain refer to tokens that have a specific use and offer utility within a particular ecosystem. The business models involved are business-to-business (B2B) business model, business to consumer (B2C) business model, and consumer-to-business (C2B) business model which have applications such as data sharing and monetization, data storage and security automated health insurance for end users such as pharmaceutical and biotechnology companies, hospitals and healthcare providers research institutes, data owners, and others.

What Is The Blockchain In Genomics Market Growth Forecast?

The blockchain in genomics market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to integration of blockchain with AI in genomics, expansion of genomic data marketplaces, increasing adoption of tokenized genomic data models, growth of b2b and b2c genomic services, rising regulatory focus on data privacy and security in genomics. Major trends in the forecast period include secure genomic data storage, blockchain-based genomic data sharing, patient consent management on blockchain, automated genomic data access control, tokenization of genomic data.

What Is The Driver Of The Blockchain In Genomics Market?

The rising adoption of digital tools is expected to propel the growth of the blockchain in genomics market going forward. Digital adoption is the process of incorporating new digital tools and systems to improve work processes and achieve objectives. The global COVID-19 pandemic served as a significant catalyst for digital adoption, with lockdowns and social distancing measures, individuals and businesses were forced to rely on digital tools for communication, education, shopping, and entertainment. Digital tools, such as software, hardware, and online platforms, are used blockchain in genomics to enhance encryption and security for genomic data, ensuring confidentiality and protection. For instance, in May 2024 according to a report published by Eurostat, a Luxembourg-based government agency, in 2023, 8.5% of individuals in the EU aged 16 to 74 participated in online consultations using the internet. Therefore, the rising demand for digital health solutions is driving the growth of blockchain in the genomics market.

Key Players In The Global Blockchain In Genomics Market

Major companies operating in the blockchain in genomics market are International Business Machines Corporation; Sharecare Inc.; WuXi Nextcode Genomics Inc.; Health Utility Network Inc.; Medicalchain Ltd.; Futura Genetics LLC; Nebula Genomics Inc.; Digital DNAtix Ltd.; EncrypGen Inc.; Longenesis; Guardtime AS; Embleema Inc.; Patientory Inc.; Shivom Ventures Limited; BurstIQ LLC; Genobank.io Inc.; LunaDNA LLC; SimplyVital Health Inc.; Zenome.io Ltd.

Global Blockchain In Genomics Market Trends and Insights

Major companies in the blockchain-in-genomics market are forming strategic partnerships to develop blockchain-based Proof of Personhood (PoP) credentials that leverage DNA testing for highly secure and sybil-resistant identity verification. For example, in February 2025, Humanity Protocol, a China-based blockchain identity verification network, partnered with Prenetics, a China-based genomics firm, to integrate Prenetics’ CircleDNA service as an official Identity Validator within Humanity Protocol’s blockchain infrastructure. This collaboration combines advanced genetic testing with zero-knowledge proof technology to create privacy-preserving PoP credentials that prevent Sybil attacks. In addition, Prenetics is establishing a Crypto Strategic Reserve by investing $1.5 million in digital assets including $H tokens, Bitcoin, and Solana to support innovation at the intersection of blockchain, healthcare, and decentralized science. The partnership aims to unite genomic accuracy with blockchain capabilities to drive decentralized identity solutions for finance, healthcare, and governance, while maintaining strong privacy protections. This marks a significant advancement in bringing DNA-based identity verification into Web3 and decentralized ecosystems.

What Are Latest Mergers And Acquisitions In The Blockchain In Genomics Market?

In May 2024, Rymedi, a US-based provider of blockchain-enabled healthcare data management platforms for diagnostic testing and clinical research, partnered with Precision Genetics. The partnership aims to improve healthcare outcomes by integrating Precision Genetics' personalized drug response solution with Rymedi's blockchain clinical trial platform. Together, they seek to reduce post-surgical drug risks and optimize recovery. This collaboration will modernize patient care and enhance overall healthcare efficiency. Precision Genetics is a US-based provider of genomic testing and precision medicine.

What Defines the Blockchain In Genomics Market?

The blockchain in genomics market includes revenues earned by entities by providing services such as data sharing and monetization, data security and privacy and data access and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The blockchain in genomics market also consists of sales of genomic supply chain tracking systems, secure storage systems, internet of things (IoT) devices, and mobile devices. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Blockchain In Genomics Market Report 2026?

The blockchain in genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blockchain in genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.